Specifically, SPS have been shown to induce cell cycle arrest at the G0/G1 phase by down-regulating CDK4 and cyclin D1 while up-regulating p21 protein expression in triple-negative breast cancer cells (MDA-MB-231). The gene discussed is CCND1; the disease is triple-negative breast carcinoma.